TickerFacts.

Endonovo Therapeutics, Inc. (ENDV): Operating Cash Flow

Annual figures by period end, from SEC filings.

Not updated since 2022-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

-$678.8K
Year ended 2022-12-31
$8.5K2010-12-31: $8.5K2011-12-31: -$50.4K2012-12-31: -$284.9K2013-12-31: -$257.4K2014-12-31: -$909.3K2015-12-31: -$1.02M2016-12-31: -$2.46M2017-12-31: -$2.99M2018-12-31: -$2.88M2019-12-31: -$2.54M2020-12-31: -$741.6K2021-12-31: -$986.6K2022-12-31: -$678.8K-$678.8K
2010-12-31 Operating Cash Flow (USD) 2022-12-31
Period endedOperating Cash FlowChange YoYSource filing
2022-12-31-$678.8Kn/m2023-04-17, From 2022-01-01
2021-12-31-$986.6Kn/m2023-04-17, From 2021-01-01
2020-12-31-$741.6Kn/m2022-04-14, From 2020-01-01
2019-12-31-$2.54Mn/m2021-04-13, From 2019-01-01
2018-12-31-$2.88Mn/m2020-05-04, From 2018-01-01
2017-12-31-$2.99Mn/m2019-04-15, From 2017-01-01
2016-12-31-$2.46Mn/m2018-04-06, From 2016-01-01
2015-12-31-$1.02Mn/m2017-04-17, From 2015-01-01
2014-12-31-$909.3Kn/m2016-05-17, From 2014-01-01
2013-12-31-$257.4Kn/m2015-06-15, From 2013-01-01
2012-12-31-$284.9Kn/m2013-05-03, From 2012-01-01
2011-12-31-$50.4Kn/m2012-04-13, From 2011-01-01
2010-12-31$8.5Kn/a2012-04-13, From 2010-01-01